Clinical Scorecard: Exploring the Factors Contributing to the Limited Use of ECT in Patients with Intellectual and Developmental Disabilities

At a Glance

Key Highlights

• Individuals with intellectual and developmental disabilities experience inequities in accessing ECT.
• ECT is comparably safe and effective for this population as for general adult cohorts.
• Historical mistrust and stigma contribute to the underutilization of ECT.
• Modern ECT practices are ethically governed and significantly safer than historical methods.
• Therapeutic nihilism affects clinician confidence in treating individuals with disabilities.

Guideline-Based Recommendations

Diagnosis

• Assess and treat individuals with intellectual and developmental disabilities with consideration of their unique presentations.

Management

• Utilize ECT as a treatment option for severe psychiatric conditions when clinically indicated.

Monitoring & Follow-up

• Ensure physiological monitoring and adherence to stringent consent processes during ECT administration.

Risks

• Untreated psychiatric conditions can lead to significant morbidity and mortality.

Patient & Prescribing Data

Individuals with intellectual and developmental disabilities experiencing severe psychiatric illness.

Effective treatment can lead to substantial improvements in mood, behavior, and quality of life.

Clinical Best Practices

• Address historical narratives and stigma surrounding ECT in discussions with patients and families.
• Provide accessible and trustworthy information about ECT to counter misinformation.
• Encourage shared decision-making and supported decision-making frameworks.

Related Resources & Content

• Source Article